Welsh, Carson, Anderson & Stowe, a private equity firm that focuses on investing in two growth industries, technology and healthcare, primarily in the United States, completed the acquisition of Leiters, a rapidly growing company in the FDA-regulated 503B outsourced pharmaceutical compounding industry. Financial terms were not disclosed. "We are very excited about our investment in Leiters. The Company is a leader in 503B outsourcing and is recognized as having one of the highest-quality operations in the industry, where quality and patient safety are paramount. Leiters represents a compelling opportunity for WCAS to leverage its capabilities in two areas where we have developed significant domain expertise: pharmaceutical services and successful collaboration with leading health systems. We are especially pleased about the opportunity to work in close partnership with some of the most forward-thinking health systems in the country as well as Leiters' CEO, Robin Smith Hoke, who is an exceptional leader," Nick O'Leary, WCAS General Partner.